GMOs Are Safe, Says Us Biotech Expert
Biggest News Source for News in Uganda and the East African Region ,Breaking news in Uganda and Daily news and the latest from Uganda
Myonexus Therapeutics Announces Accelerated Acquisition by Sarepta Therapeutics | Business Wire
Myonexus Therapeutics Announces Accelerated Acquisition by Sarepta Therapeutics Following Positive Preliminary Data from LGMD2E Program
Novartis announces new CEO of Oncology Business Unit
Novartis have appointed Susanne Schaffert, Ph.D., as the new CEO of Novartis Oncology Novartis announced that Susanne Schaffert, Ph.D., currently President, Advanced Accelerator Applications (AAA), a Novartis company, has been appointed CEO Novartis Oncology. She will report to Vas Narasimhan, CEO, Novartis, and will join the Executive Committee on January 1, 2019. Liz Barrett will be...
FDA Approves MAVENCLAD® (Cladribine) Tablets as First and Only Short-Course Oral...
ROCKLAND, Mass., March 29, 2019 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada
FLIR Systems Acquires Aeryon Labs for $200M | Business Wire
FLIR Systems, Inc. (NASDAQ: FLIR) announced today that it has acquired Aeryon Labs Inc., a leading developer of high-performance unmanned aerial syste
AveXis Presents Data Showing Efficacy Of Zolgensma In Broad Spectrum Of...
AveXis, a Novartis company, announced interim data from ongoing trials of the investigational product Zolgensma or onasemnogene abeparvovec-xioi; AVXS-101 that showed positive results across a broad spectrum of patients with spinal muscular atrophy or SMA.
Sobi™ to Acquire Synagis® US Rights From AstraZeneca – Creates a...
Sobi™ to Acquire Synagis® US Rights From AstraZeneca - Creates a Platform for Global Growth - read this article along with other careers information, tips and advice on BioSpace
Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray...
TITUSVILLE, N.J., March 5, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced the U.S. Food and Drug Administratio
Vertex Appoints Charles Wagner as Chief Financial Officer | Business Wire
Vertex today announced the appointment of Charles Wagner as Executive Vice President and Chief Financial Officer, effective April 10, 2019.